 |
Putting
the NICE Guideline on Type 2 Diabetes into Practice |
| |
In this article, we will focus on the important
areas of patient education, dietary assessment, setting targets
for HbA1c, self-monitoring and starting insulin therapy. 4-page
PDF (British Journal of Primary Care Nursing) |
| |
|
|
Why
do People with Diabetes Fall Off the Rails? |
| |
This article reviews what I found and offers
some suggestions on how to help patients get back in control. 3-page
PDF (British Journal of Primary Care Nursing) |
| |
|
|
Tackling
Type 2 diabetes prevention |
| |
Diabetes UK held its first Frontiers in Diabetes
meeting this week. The event looked at generating practical strategies
for the prevention of Type 2 diabetes in the UK (Diabetes UK) |
| |
|
|
GPs
in Scotland have wider type-2 diabetes treatment choice |
| |
GPs in Scotland now have a wider choice of treatments
for type-2 diabetes following acceptance of the dipeptidyl peptidase
4 (DPP-4) inhibitor sitagliptin by the Scottish Medicines Consortium
(Healthcare Republic) |
| |
|
|
Obesity
Upregulates Genes Involved in Oxidative Phosphorylation in Livers
of Diabetic Patients |
| |
Obesity may affect the pathophysiology of type
2 diabetes by upregulating genes involved in OXPHOS in association
with insulin resistance markers and the expression of genes involved
in hepatic gluconeogenesis and ROS generation (Obesity) |
| |
|
|
Clinical
resolution of glycogenic hepatopathy following improved glycemic
control |
| |
Glycogenic hepatopathy is an underrecognized
complication of long-standing poorly controlled diabetes mellitus
... It is important to distinguish this entity as it has the potential
for resolution following improved glycemic control as described
by this case report (Journal of Diabetes and its Complications) |
| |
|
|
Telmisartan
may be potential treatment for high-risk diabetes, vascular disease |
| |
Patients with vascular disease or high-risk
diabetes who are unable to tolerate ACE inhibitors may have reduced
cardiovascular death, myocardial infarction or stroke with telmisartan
treatment (Endocrine today) |
| |
|
|
The
Incidence of Tinea Pedis in Diabetic versus Nondiabetic Patients
with Interdigital Macerations |
| |
The prevalence in the nondiabetic group was
37.5% and 42.5% for the diabetic group. This was not a statistically
significant difference (Journal of the American Podiatric Medical
Association) |
| |
|
